References
- SahaSChantDWelhamJMcGrathJA systematic review of the prevalence of schizophreniaPLoS Med200525e14115916472
- HennekensCHHennekensARHollarDCaseyDESchizophrenia and increased risks of cardiovascular diseaseAm Heart J200515061115112116338246
- ZornbergGLJickHAntipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control studyLancet200035692371219122311072939
- LiperotiRPedoneCLapaneKLMorVBernabeiRGambassiGVenous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agentsArch Intern Med2005165222677268216344428
- WalkerAMLanzaLLArellanoFRothmanKJMortality in current and former users of clozapineEpidemiology1997866716779345668
- ParkinLSkeggDCHerbisonGPPaulCPsychotropic drugs and fatal pulmonary embolismPharmacoepidemiol Drug Saf200312864765214762980
- HamanakaSKamijoYNagaiTMassive pulmonary thromboembolism demonstrated at necropsy in Japanese psychiatric patients treated with neuroleptics including atypical antipsychoticsCirc J200468985085215329507
- LacutKLe GalGCouturaudFAssociation between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control studyFundam Clin Pharmacol200721664365018034665
- MasopustJMalýRUrbanAHosákLCermákováEAntipsychotic drugs as a risk factor for venous thromboembolismInt J Psychiatr Clin Pract2006113246249
- HäggSBateAStåhlMSpigsetOAssociations between venous thromboembolism and antipsychotics: A study of the WHO Database of Adverse Drug ReactionsDrug Saf200831868569418636787
- JönssonAKBrudinLAhlnerJHedenmalmKErikssonAHäggSAntipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy seriesInt Clin Psychopharmacol200823526326818703935
- RayJGMamdaniMMYeoELAntipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolismThromb Haemost200288220520912195690
- HallasJConducting pharmacoepidemiologic research in DenmarkPharmacoepidemiol Drug Saf200110761962311980250
- RosendaalFRVenous thrombosis: the role of genes, environment, and behaviorHematology Am Soc Hematol Educ Program200511216304352
- GlynnRJRosnerBComparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolismAm J Epidemiol20051621097598216207808
- Tillie-LeblondIMarquetteCHPerezTPulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factorsAnn Intern Med2006144639039616549851
- MotykieGDZebalaLPCapriniJAA guide to venous thromboembolism risk factor assessmentJ Thromb Thrombolysis20009325326210728025
- AgenoWBecattiniCBrightonTSelbyRKamphuisenPWCardiovascular risk factors and venous thromboembolism: a meta-analysisCirculation200811719310218086925
- RayJGMamdaniMTsuyukiRTAndersonDRYeoELLaupacisAUse of statins and the subsequent development of deep vein thrombosisArch Intern Med2001161111405141011386889
- Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trialLancet200035592121295130210776741
- LidegaardOEdstromBKreinerSOral contraceptives and venous thromboembolism: a five-year national case-control studyContraception200265318719611929640
- FisherESWhaleyFSKrushatWMThe accuracy of Medicare’s hospital claims data: progress has been made, but problems remainAm J Public Health19928222432481739155
- BeratisSKatrivanouAGourzisPFactors affecting smoking in schizophreniaCompr Psychiatry200142539340211559866
- PompERRosendaalFRDoggenCJSmoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive useAm J Hematol20088329710217726684
- CurranSTurnerDMusaSWattisJPsychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groupsInt J Geriatr Psychiatry200520984284716116576
- HäggSSpigsetOAntipsychotic-induced venous thromboembolism: a review of the evidenceCNS Drugs2002161176577612383032
- OwensDGAdverse effects of antipsychotic agents. Do newer agents offer advantages?Drugs19965168959308736614
- WagstaffABrysonHClozapine: a review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agentsCNS Drugs19954370400
- AgenoWSquizzatoAGarciaDImbertiDEpidemiology and risk factors of venous thromboembolismSemin Thromb Hemost200632765165817024592
- AllisonDBMentoreJLHeoMAntipsychotic-induced weight gain: a comprehensive research synthesisAm J Psychiatry1999156111686169610553730
- WallaschofskiHEigenthalerMKieferMHyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot studyJ Clin Psychopharmacol200323547948314520125
- AxelssonSHäggSErikssonACLindahlTLWhissPAIn vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulationClin Exp Pharmacol Physiol200734877578017600556
- CattaneoMHyperhomocysteinemia and venous thromboembolismSemin Thromb Hemost200632771672317024599
- HaidemenosAKontisDGaziAKallaiEAllinMLuciaBPlasma homocysteine, folate and B12 in chronic schizophreniaProg Neuropsychopharmacol Biol Psychiatry20073161289129617597277